-
1
Precisely calibrated small microspheres• Sized for tumor penetration at 40 μm, 75 μm, and 100 μm
• ≥95% of Oncozene Microspheres are within the specified size range[1]
-
2
Strength in numbers to deliver more microspheres• Greater number of small microspheres facilitates homogenous tumor coverage[2-4]
• Single unit syringes are available in 2 ml or 3 ml options to deliver even more microspheres
-
3
Indicated for the embolization of:• Arteriovenous malformations
• Hypervascular tumors including hepatoma
This device is not intended for neurovascular use.
Resources
-
Date on file. Varian Medical Systems, Inc. 2020.
-
Delicque, J., et al., Liver chemoembolization of hepatocellular carcinoma using TANDEM® microspheres. Future Oncol, 2018. 14(26): p. 2761-2772.
-
Tanaka, T., et al., Pharmacokinetics and antitumor efficacy of chemoembolization using 40 micron irinotecan-loaded microspheres in a rabbit liver tumor model. J Vasc Interv Radiol, 2014. 25(7): p. 1037-1044 e2.
-
She, H.L., et al., In Vivo Proof of Superselective Transarterial Chemoembolization with 40-µm Drug-Eluting Beads in a Patient with Hepatocellular Carcinoma. Cardiovasc Intervent Radiol, 2016. 39(1): p. 137-40.
-
Blümmel, J., et al., Drug-eluting Beads in the Treatment of Hepatocellular Carcinoma and Colorectal Cancer Metastases to the Liver. European Oncology and Haematology, 2012. 8: p.162-166.
We’ll help you get connected
Contact Varian’s Interventional Oncology Customer support team
+1 877-467-2009 or vis.support@varian.com.